4//SEC Filing
Tribble Diane L. 4
Accession 0001181431-11-014652
CIK 0001338042other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:22 PM ET
Size
6.2 KB
Accession
0001181431-11-014652
Insider Transaction Report
Form 4
Tribble Diane L.
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2011-03-01+220,000→ 220,000 totalExercise: $14.84Exp: 2021-03-01→ Common Stock (220,000 underlying)
Footnotes (2)
- [F1]The stock option award has an exercise price equal to the fair market value of Aergerion Pharmaceuticals, Inc.'s common stock on the date of grant, March 1, 2011.
- [F2]60% of the shares of common stock underlying this stock option vest in equal monthly installments over a four year period commencing immediately upon the date of hire, February 17, 2011; and 40% of the shares of common stock underlying this stock option vest in equal monthly installments over a four year period commencing upon marketing approval of Lomitapide by the U.S. Food and Drug Administration.
Documents
Issuer
Aegerion Pharmaceuticals, Inc.
CIK 0001338042
Entity typeother
Related Parties
1- filerCIK 0001513462
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 5:22 PM ET
- Size
- 6.2 KB